US patent for Avanir Pharma's low-dose quinidine formulations of Zeniva
Saturday, February 13, 2010 13:00 IST Aliso Viejo, California
Avanir Pharmaceuticals, Inc announced that the United States Patent and Trademark Office (US PTO) has issued the company a new patent for its lead drug candidate Zenvia